| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| siponimod | sphingosine 1-phosphate receptor 1 | small molecule | NA | drugbank , DGIDB | Disease[MeSHID:D004194] Multiple Sclerosis[MeSHID:D009103] Neoplasm Metastasis[MeSHID:D009362] Syndrome[MeSHID:D013577] Relapse[MeSHID:D012008] Rheumatoid Arthritis[MeSHID:D001172] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Liver carcinoma[MeSHID:D006528] |
3.64 | approved,investigational | agonist |
| siponimod | sphingosine-1-phosphate receptor 1 | NA | Successful target | TTD , DGIDB | Disease[MeSHID:D004194] Multiple Sclerosis[MeSHID:D009103] Neoplasm Metastasis[MeSHID:D009362] Syndrome[MeSHID:D013577] Relapse[MeSHID:D012008] Rheumatoid Arthritis[MeSHID:D001172] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Liver carcinoma[MeSHID:D006528] |
3.64 | approved | agonist |
| siponimod | sphingosine 1-phosphate receptor 5 | small molecule | NA | drugbank , DGIDB | Disease[MeSHID:D004194] Multiple Sclerosis[MeSHID:D009103] Neoplasm Metastasis[MeSHID:D009362] Syndrome[MeSHID:D013577] Relapse[MeSHID:D012008] Rheumatoid Arthritis[MeSHID:D001172] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Liver carcinoma[MeSHID:D006528] |
7.96 | approved,investigational | modulator,agonist |
| click here to return to the previous page | ||||||||